Virtual Town Hall Series - Immediately in Effect Guidance on Coronavirus (COVID-19) Diagnostic Tests - 08/19/2020 - 08/19/2020 | FDA

Virtual Town Hall Series - Immediately in Effect Guidance on Coronavirus (COVID-19) Diagnostic Tests - 08/19/2020 - 08/19/2020 | FDA

Events

• Today! August 19, 2020: Virtual Town Hall Series - Immediately in Effect Guidance on Coronavirus (COVID-19) Diagnostic Tests - FDA will host a virtual Town Hall for clinical laboratories and commercial manufacturers that are developing or have developed diagnostic tests for SAR-CoV-2, 12:15 p.m. - 1:15 p.m. ET. FDA will host additional town halls in this series on Wednesdays in August. There is significant interest in this Town Hall. Connecting early is highly recommended. To ensure you are connected, please dial-in at 12:00 p.m.
• August 25-27, 2020: Preparedness Summit (virtual) - FDA's Elizabeth Sadove, JD, will present along with CDC speakers as part of the session "Federal Regulatory Updates on Use of Medical Countermeasures." (fee)
• September 1, 2020: Save the date for the next event in FDA's webinar series to share information and answer your questions on respirators and other personal protective equipment (PPE). Printable slides and transcripts from previous events in this series are available.
• September 17-18, 2020: Considerations for the Use of Real-World Evidence to Assess the Effectiveness of Preventive Vaccines - virtual workshop - agenda (PDF)
• October 2, 2020: Vaccines and Related Biological Products Advisory Committee (webcast) - At this meeting the committee will recommend strains for the 2021 Southern Hemisphere influenza vaccines licensed in the U.S., which is part of FDA’s year-round efforts to flight flu, along with other public health partners like CDC and NIH.